Brainstorm Cell Therapeutics Inc.
USD0.90
-0.00 (-0.01%)
CEO
Chaim Lebovits
IPO Date
2003-10-07
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.90
Prev. Close
$0.90
Day Low
$0.90
Day High
$0.90
52W Low
$0.46
52W High
$1.32
Market Cap
$0.01B
Volume
0.00M
| 1,800,000 |
| $0.00 |
| 29 May 2026 | Yablonka Uri | director, officer: EVP & Chief Business Officer | A-Award | Acquired | 150,000 | $0.00 |
| 29 May 2026 | Patlis Alla | See Remarks | A-Award | Acquired | 100,000 | $0.00 |
| 29 May 2026 | FRENKEL JACOB A | director | A-Award | Acquired | 200,000 | $0.00 |
| 29 May 2026 | ARBEL IRIT | director | A-Award | Acquired | 120,000 | $0.00 |
| 20 May 2026 | Bairu Menghisteab | director | A-Award | Acquired | 150,000 | $0.70 |
| 20 May 2026 | Polverino Anthony J. | director | A-Award | Acquired | 150,000 | $0.70 |
| 20 May 2026 | HARTOUNIAN HARTOUN | director | A-Award | Acquired | 225,000 | $0.70 |
| 20 May 2026 | Lindborg Stacy | director | A-Award | Acquired | 150,000 | $0.70 |